1276680-73-9

Basic information

• Product Name: 3-(4-fluorophenyl)-7-{[5-(1-hydroxy-1-trifluoromethylpropyl)[1,3,4]oxadiazol-2-ylamino]methyl}indolizine-2-carboxylic acid ethyl ester
• Synonyms: 3-(4-fluorophenyl)-7-{[5-(1-hydroxy-1-trifluoromethylpropyl)[1,3,4]oxadiazol-2-ylamino]methyl}indolizine-2-carboxylic acid ethyl ester
• CAS NO: 1276680-73-9
• Molecular Weight: 506.457
• Mol File: 1276680-73-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(4-fluorophenyl)-7-{[5-(1-hydroxy-1-trifluoromethylpropyl)[1,3,4]oxadiazol-2-ylamino]methyl}indolizine-2-carboxylic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-fluorophenyl)-7-{[5-(1-hydroxy-1-trifluoromethylpropyl)[1,3,4]oxadiazol-2-ylamino]methyl}indolizine-2-carboxylic acid ethyl ester(1276680-73-9)
• EPA Substance Registry System: 3-(4-fluorophenyl)-7-{[5-(1-hydroxy-1-trifluoromethylpropyl)[1,3,4]oxadiazol-2-ylamino]methyl}indolizine-2-carboxylic acid ethyl ester(1276680-73-9)

Safety Data

• Hazardous Substances Data: 1276680-73-9(Hazardous Substances Data)

Upstream product

• 1276680-67-1 3-(4-fluorophenyl)-7-hydroxymethylindolizine-2-carboxylic acid ethyl ester 
• 1276680-66-0 7-hydroxymethylindolizine-2-carboxylic acid ethyl ester 
• 1276680-65-9 7-(tert-butyldimethylsilanyloxymethyl)indolizine-2-carboxylic acid ethyl ester 
• 1006302-00-6 4-(tert-butyl-dimethyl-silanyloxymethyl)-2-methyl-pyridine 
• 910656-45-0 2-hydroxy-2-trifluoromethylbutyric acid hydrazide 
• 910656-46-1 2-(5-amino-[1,3,4]oxadiazol-2-yl)-1,1,1-trifluorobutan-2-ol 
• 1276680-74-0 3-(4-fluorophenyl)-7-formylindolizine-2-carboxylic acid ethyl ester 
• 16830-24-3 methyl 2-methylisonicotinate 
• 105250-16-6 (2-methylpyridin-4-yl)methanol 
• 22282-99-1 4-bromo-2-methylpyridine 

Relevant articles and documents

INDOLIZINE INHIBITORS OF 5-LIPOXYGENASE

Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.